COMPANY
Intrinsic Therapeutics
FDA-cleared device company Clinical Phase 3
Timeline
- Trial start Phase 4: Return to Activity After Surgery for Lumbar Disc Herniation source ↗
- Trial start —: PMCFU of an Annular Closure System source ↗
- Trial start —: Incidence of Large Annular Defects in Primary Lumbar Discectomy Patients source ↗
- Trial start Not phased (device or behavioral study): Study of Lumbar Discectomy With Annular Closure source ↗
- Trial start Phase 4: A Post Marketing Surveillance Study source ↗
- Trial start —: Post-Marketing Clinical Follow-Up of a Spine Implant source ↗
- Trial start —: Lumbar Discectomy Control Study, Risk Factors for Reherniation source ↗
- Trial start Phase 4: A Prospective, Randomized, Multicenter Study to Demonstrate the Superiority of the Barricaid to Discectomy for Primary Lumbar Disc Herniation source ↗
- Trial start Not phased (device or behavioral study): Barricaid EU Post Market Study for Primary Lumbar Disc Herniation source ↗
Upcoming milestones
- Oct 1, 2027 (ESTIMATED) · Phase 4 · Return to Activity After Surgery for Lumbar Disc Herniation · NCT07667348
Clinical trials (lead sponsor) 9
| Record | Title | Phase | Status | Start | Primary completion |
|---|---|---|---|---|---|
| NCT07667348 | Return to Activity After Surgery for Lumbar Disc Herniation | Phase 4 | Not yet recruiting | Jun 30, 2026 | Oct 1, 2027 (estimated) |
| NCT03366779 | A Post Marketing Surveillance Study | Phase 4 | Unknown status (ClinicalTrials.gov) | Jan 16, 2018 | 2024-06 (estimated) |
| NCT05467072 | PMCFU of an Annular Closure System | Not listed | Unknown status (ClinicalTrials.gov) | Sep 27, 2023 | 2024-10 (estimated) |
| NCT03180749 | Post-Marketing Clinical Follow-Up of a Spine Implant | Not listed | Unknown status (ClinicalTrials.gov) | Mar 2, 2017 | 2024-06 (estimated) |
| NCT03986580 | Study of Lumbar Discectomy With Annular Closure | Not phased (device or behavioral study) | Unknown status (ClinicalTrials.gov) | May 1, 2020 | 2024-06 (estimated) |
| NCT01283438 | A Prospective, Randomized, Multicenter Study to Demonstrate the Superiority of the Barricaid to Discectomy for Primary Lumbar Disc Herniation | Phase 4 | Unknown status (ClinicalTrials.gov) | Dec 17, 2010 | 2016-10 (actual) |
| NCT02477176 | Lumbar Discectomy Control Study, Risk Factors for Reherniation | Not listed | Unknown status (ClinicalTrials.gov) | Feb 17, 2016 | 2024-03 (estimated) |
| NCT01534065 | Barricaid EU Post Market Study for Primary Lumbar Disc Herniation | Not phased (device or behavioral study) | Completed | 2009-04 | 2013-03 (actual) |
| NCT03252691 | Incidence of Large Annular Defects in Primary Lumbar Discectomy Patients | Not listed | Withdrawn | 2020-09 | 2021-04 (estimated) |